NO873231L - Diselenobis-benzosyreamider av primaere heterocykliske aminer, samt fremgangsmaate for fremstilling av forbindelsene. - Google Patents
Diselenobis-benzosyreamider av primaere heterocykliske aminer, samt fremgangsmaate for fremstilling av forbindelsene.Info
- Publication number
- NO873231L NO873231L NO873231A NO873231A NO873231L NO 873231 L NO873231 L NO 873231L NO 873231 A NO873231 A NO 873231A NO 873231 A NO873231 A NO 873231A NO 873231 L NO873231 L NO 873231L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- diselenobis
- heterocyclic amines
- nitro
- alkoxy
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 150000001412 amines Chemical class 0.000 title 1
- -1 heterocyclic amines Chemical class 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical class NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 abstract 1
- 206010061216 Infarction Diseases 0.000 abstract 1
- 206010067125 Liver injury Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000005864 Sulphur Substances 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000005779 cell damage Effects 0.000 abstract 1
- 208000037887 cell injury Diseases 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 231100000234 hepatic damage Toxicity 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000007574 infarction Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000008818 liver damage Effects 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 150000002926 oxygen Chemical class 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000005855 radiation Effects 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/36—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Furan Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19863626554 DE3626554A1 (de) | 1986-08-06 | 1986-08-06 | Diselenobis-benzoesaeureamide primaerer heterocyclischer amine, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische praeparate |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO873231D0 NO873231D0 (no) | 1987-08-03 |
| NO873231L true NO873231L (no) | 1988-02-08 |
| NO171215B NO171215B (no) | 1992-11-02 |
| NO171215C NO171215C (no) | 1993-02-10 |
Family
ID=6306768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO873231A NO171215C (no) | 1986-08-06 | 1987-08-03 | Analogifremgangsmaate for fremstilling av terapeutisk virksomme diselenobis-benzosyreamider |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4910313A (no) |
| EP (1) | EP0257306B1 (no) |
| JP (1) | JPH0830060B2 (no) |
| KR (1) | KR960001202B1 (no) |
| AT (1) | ATE56436T1 (no) |
| AU (1) | AU598285B2 (no) |
| CA (1) | CA1303038C (no) |
| DD (1) | DD261597A5 (no) |
| DE (2) | DE3626554A1 (no) |
| DK (1) | DK169407B1 (no) |
| ES (1) | ES2017483B3 (no) |
| FI (1) | FI85018C (no) |
| GR (1) | GR3001180T3 (no) |
| HU (1) | HU197753B (no) |
| IE (1) | IE60366B1 (no) |
| NO (1) | NO171215C (no) |
| PT (1) | PT85501B (no) |
| SU (1) | SU1597097A3 (no) |
| ZA (1) | ZA875821B (no) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5128365A (en) * | 1989-07-19 | 1992-07-07 | The Trustees Of Columbia University In The City Of New York | Compounds having glutathione peroxidase activity and use thereof |
| DE3937170A1 (de) * | 1989-11-08 | 1991-05-16 | Nattermann A & Cie | Benzylselenobenzamide von aminopyridinen und picolylaminen |
| DE3937171A1 (de) * | 1989-11-08 | 1991-05-16 | Nattermann A & Cie | Picolylselenobenzamide von aminopyridinen, anilinen und picolylaminen |
| DK0622076T3 (da) * | 1992-01-17 | 1997-06-02 | Daiichi Seiyaku Co | Inhibitor for restenose efter perkutan coronar arterioplasti |
| FR2757857B1 (fr) * | 1996-12-27 | 1999-04-23 | Oxis International Sa | Diselenures et selenosulfures aromatiques, leur preparation et leurs utilisations, notamment therapeutiques |
| HK1042082A1 (en) | 1999-03-31 | 2002-08-02 | Holmgren Arne | Substrates for thioredoxin reductase |
| US7776925B2 (en) * | 2002-03-06 | 2010-08-17 | Duke University | Reversing, postponing or preventing the occurrence of GTN tolerance and/or generation of reactive oxygen species from mitochondria |
| US10058542B1 (en) | 2014-09-12 | 2018-08-28 | Thioredoxin Systems Ab | Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3027073C2 (de) * | 1980-07-17 | 1985-03-07 | A. Nattermann & Cie GmbH, 5000 Köln | Pharmazeutische Präparate, enthaltend 2-Phenyl-1,2-benzisoselenazol-3(2H)-on |
| DE3027075A1 (de) * | 1980-07-17 | 1982-02-18 | A. Nattermann & Cie GmbH, 5000 Köln | Benzisoselenazolone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
| DE3027074A1 (de) * | 1980-07-17 | 1982-02-18 | A. Nattermann & Cie GmbH, 5000 Köln | Benzisoselenazolon enthaltende pharmazeutische praeparate und ihre verwendung |
| DE3226284A1 (de) * | 1982-07-14 | 1984-01-19 | A. Nattermann & Cie GmbH, 5000 Köln | Neue benzisoselenazolone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
| DE3568775D1 (en) * | 1984-06-22 | 1989-04-20 | Nattermann A & Cie | S-(carbamoyl-phenylselenyl) derivatives of glutathion and of amino mercaptocarboxylic acids, process for their preparation and pharmaceutical preparations containing them |
| DE3443467A1 (de) * | 1984-11-29 | 1986-05-28 | A. Nattermann & Cie GmbH, 5000 Köln | Mercaptanderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
| EP0198277B1 (de) * | 1985-04-12 | 1989-05-03 | A. Nattermann & Cie. GmbH | Diselenobis-benzoesäureamide primärer und sekundärer Amine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate |
| DE3515272C2 (de) * | 1985-04-27 | 1993-10-14 | Nattermann A & Cie | Benzisoselenazolone, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate |
-
1986
- 1986-08-06 DE DE19863626554 patent/DE3626554A1/de not_active Withdrawn
-
1987
- 1987-07-23 AT AT87110648T patent/ATE56436T1/de not_active IP Right Cessation
- 1987-07-23 ES ES87110648T patent/ES2017483B3/es not_active Expired - Lifetime
- 1987-07-23 DE DE8787110648T patent/DE3764910D1/de not_active Expired - Lifetime
- 1987-07-23 EP EP87110648A patent/EP0257306B1/en not_active Expired - Lifetime
- 1987-07-27 IE IE203387A patent/IE60366B1/en not_active IP Right Cessation
- 1987-07-30 CA CA000543452A patent/CA1303038C/en not_active Expired - Fee Related
- 1987-08-03 NO NO873231A patent/NO171215C/no unknown
- 1987-08-04 FI FI873383A patent/FI85018C/fi not_active IP Right Cessation
- 1987-08-05 HU HU873576A patent/HU197753B/hu not_active IP Right Cessation
- 1987-08-05 DK DK409087A patent/DK169407B1/da not_active IP Right Cessation
- 1987-08-06 DD DD87305765A patent/DD261597A5/de not_active IP Right Cessation
- 1987-08-06 KR KR1019870008679A patent/KR960001202B1/ko not_active Expired - Fee Related
- 1987-08-06 US US07/082,438 patent/US4910313A/en not_active Expired - Fee Related
- 1987-08-06 AU AU76651/87A patent/AU598285B2/en not_active Ceased
- 1987-08-06 ZA ZA875821A patent/ZA875821B/xx unknown
- 1987-08-06 JP JP62195406A patent/JPH0830060B2/ja not_active Expired - Lifetime
- 1987-08-06 PT PT85501A patent/PT85501B/pt active IP Right Revival
- 1987-08-06 SU SU874203234A patent/SU1597097A3/ru active
-
1990
- 1990-12-11 GR GR90401048T patent/GR3001180T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK409087D0 (da) | 1987-08-05 |
| KR880002889A (ko) | 1988-05-12 |
| ATE56436T1 (de) | 1990-09-15 |
| IE60366B1 (en) | 1994-07-13 |
| FI85018B (fi) | 1991-11-15 |
| PT85501A (en) | 1987-09-01 |
| NO171215C (no) | 1993-02-10 |
| NO873231D0 (no) | 1987-08-03 |
| HU197753B (en) | 1989-05-29 |
| NO171215B (no) | 1992-11-02 |
| AU598285B2 (en) | 1990-06-21 |
| AU7665187A (en) | 1988-02-11 |
| HUT44572A (en) | 1988-03-28 |
| KR960001202B1 (ko) | 1996-01-24 |
| JPH0830060B2 (ja) | 1996-03-27 |
| FI873383A0 (fi) | 1987-08-04 |
| DE3626554A1 (de) | 1988-02-18 |
| ZA875821B (en) | 1988-02-10 |
| DE3764910D1 (de) | 1990-10-18 |
| EP0257306B1 (en) | 1990-09-12 |
| FI85018C (fi) | 1992-02-25 |
| CA1303038C (en) | 1992-06-09 |
| IE872033L (en) | 1988-02-06 |
| GR3001180T3 (en) | 1992-06-30 |
| US4910313A (en) | 1990-03-20 |
| PT85501B (pt) | 1990-06-29 |
| SU1597097A3 (ru) | 1990-09-30 |
| ES2017483B3 (es) | 1991-02-16 |
| EP0257306A1 (en) | 1988-03-02 |
| JPS6379875A (ja) | 1988-04-09 |
| FI873383L (fi) | 1988-02-07 |
| DK409087A (da) | 1988-02-07 |
| DK169407B1 (da) | 1994-10-24 |
| DD261597A5 (de) | 1988-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI892787A0 (fi) | Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-indolyylialkyyli-4-(substituoitu pyridinyyli)piperatsiinien valmistamiseksi | |
| ES8603408A1 (es) | Un procedimiento para la preparacion de un compuesto de 2-oxindol-1-carboxamida | |
| ES2164164T3 (es) | Derivados de aminotetrazol utiles como inhibidores de oxido nitrico sintasa. | |
| IT1229570B (it) | Derivati fluorurati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono. | |
| SE8504014L (sv) | Etylendiaminmonoamid-derivat | |
| IT1229569B (it) | Derivati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono. | |
| FI942882A7 (fi) | Substituoituja imidatsolijohdannaisia ja niiden valmistus ja käyttö | |
| NO873231D0 (no) | Diselenobis-benzosyreamider av primaere heterocykliske aminer, samt fremgangsmaate for fremstilling av forbindelsene. | |
| DK163144C (da) | Diethylaminoalkoxybenzhydrolderivater og farmaceutisk acceptable syreadditionssalte og kvaternaere ammoniumsalte deraf, fremgangsmaade til fremstilling heraf, farmaceutisk praeparat og fremgangsmaade til fremstilling heraf | |
| ES2129073T3 (es) | Derivados del acido 4-fenilcarbamoil-3-isoxazol-carboxilico con actividad antiinflamatoria. | |
| ATE48276T1 (de) | 1,6-naphthyridin-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel. | |
| FR2449677B1 (fr) | Nouveaux derives de benzoyl-2 glycylanilides substitues, leur preparation et leur application en tant que medicaments anxiolytiques | |
| NO159927C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aromatiske aminoacetylener. | |
| LV5491A3 (lv) | 2-tiazolidinona atvasinajumu iegusanas panemiens | |
| HUT40658A (en) | Process for producing benzo/c/-1,5-naphtiridin derivatives and pharmaceutical compositions containing them as active agents | |
| DE3781783D1 (de) | N-alkyl-derivate von 2-amino-6,7-dimethoxytetralin, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen mit antihypertensiver wirkung. | |
| ES2001420A6 (es) | Procedimiento para la preparacion de derivados de naftaleno. | |
| ES8100257A1 (es) | Procedimiento de preparacion de un derivado ciclododecano | |
| ATE95697T1 (de) | Uricosuretische zusammensetzung. | |
| ES2056211T3 (es) | Derivados de acilsulfonamida de acidos alfa-carbocicliltoluicos usados como antagonistas de leucotrienos. | |
| IT1210914B (it) | Eterociclilfenilsolfonil e fosfonilamidine sostituite, procedimento per la loro preparazione e loro uso farmaceutico. | |
| EA200100163A1 (ru) | Новые производные 6-деоксиэритромицина, способ их получения и их применение в качестве лекарственных средств |